Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Non-Current Deferred Tax Liability (2016 - 2018)

Apyx Medical (APYX) has disclosed Non-Current Deferred Tax Liability for 7 consecutive years, with $368000.0 as the latest value for Q2 2018.

  • For the quarter ending Q2 2018, Non-Current Deferred Tax Liability fell 34.75% year-over-year to $368000.0, compared with a TTM value of $368000.0 through Jun 2018, down 34.75%, and an annual FY2017 reading of $368000.0, down 34.75% over the prior year.
  • Non-Current Deferred Tax Liability was $368000.0 for Q2 2018 at Apyx Medical, roughly flat from $368000.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $760000.0 in Q4 2015 and bottomed at $368000.0 in Q4 2017.
  • Average Non-Current Deferred Tax Liability over 4 years is $515000.0, with a median of $564000.0 recorded in 2016.
  • The sharpest move saw Non-Current Deferred Tax Liability dropped 25.79% in 2016, then tumbled 34.75% in 2017.
  • Year by year, Non-Current Deferred Tax Liability stood at $760000.0 in 2015, then decreased by 25.79% to $564000.0 in 2016, then tumbled by 34.75% to $368000.0 in 2017, then changed by 0.0% to $368000.0 in 2018.
  • Business Quant data shows Non-Current Deferred Tax Liability for APYX at $368000.0 in Q2 2018, $368000.0 in Q1 2018, and $368000.0 in Q4 2017.